Keyphrases
Interferon-α (IFN-α)
100%
Cutaneous T-cell Lymphoma
100%
Phototherapy
100%
Interferon alpha-2b
100%
Toxic Effects
50%
Patient Response
25%
Phase II Study
25%
Maximum Tolerated Dose
25%
Phase I Trial
25%
Disease Stage
25%
Overall Response Rate
25%
Highly Effective
25%
Fever
25%
Extended Period
25%
Complete Remission
25%
Duration of Response
25%
Escalating Dose
25%
Constitutional Symptoms
25%
Psoralen
25%
Partial Response
25%
Mental Status Change
25%
UV Radiation
25%
Intramuscularly
25%
Malaise
25%
Recombinant Interferon
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cutaneous T Cell Lymphoma
100%
Alpha2a Interferon
100%
Interferon
100%
PUVA Therapy
50%
Phase I Trials
25%
Photosensitivity
25%
Malignant Neoplasm
25%
Remission
25%
Side Effect
25%
Recombinant Alpha2a Interferon
25%
Malaise
25%
Maximum Tolerated Dose
25%
Psoralen
25%
Diseases
25%